Exploitation of the nicotinic anti-inflammatory pathway for the treatment of epithelial inflammatory diseases.
about
Reflex principles of immunological homeostasisThe influence of nicotine on granulocytic differentiation - inhibition of the oxidative burst and bacterial killing and increased matrix metalloproteinase-9 releaseInhibition of Toll-like receptor 2-mediated interleukin-8 production in Cystic Fibrosis airway epithelial cells via the alpha7-nicotinic acetylcholine receptorTobacco upregulates P. gingivalis fimbrial proteins which induce TLR2 hyposensitivity.Biomarkers of thyroid function and autoimmunity for predicting high-risk groups of thyroid cancer: a nested case-control studyNeutrophils in periodontal inflammationNicotine inhibits memory CTL programmingTobacco use increases susceptibility to bacterial infection.Neuronal nicotinic receptors as novel targets for inflammation and neuroprotection: mechanistic considerations and clinical relevance.Alpha7 nicotinic receptors as novel therapeutic targets for inflammation-based diseases.What can we learn about biofilm/host interactions from the study of inflammatory bowel disease.Pustulotic arthro-osteitis associated with palmoplantar pustulosis.Effect of nicotine, cotinine and cigarette smoke extract on the neutrophil respiratory burst.Smoking and gingivitis: focus on inducible nitric oxide synthase, nitric oxide and basic fibroblast growth factor.Is the effect of smoking on rosacea still somewhat of a mystery?Neuronal nicotinic alpha7 receptors modulate early neutrophil infiltration to sites of skin inflammation.Smoking, use of moist snuff, and risk of chronic inflammatory diseases.The role of IL-1β in nicotine-induced immunosuppression and neuroimmune communication.
P2860
Q27026999-651CF001-62D0-455C-A18C-D5153DE834AFQ33328296-EC523886-ECAB-4E92-AAA5-B33FE76BAF62Q33551176-1CF5AB51-070C-48B9-A375-80B2B4FA9F30Q33573373-9E299A11-4015-4738-AC65-08912747CF08Q34895975-DBBAFB0C-D492-4B25-84AD-997F5A987F78Q35909279-918423A9-2C23-4DD7-8CE5-62405262480EQ36976461-A19DA437-8778-4C94-A6E6-871B6987521EQ37066146-27CF89DF-1325-468A-B75D-E052EEDF6565Q37508584-0461DDDB-E525-4DFB-96BA-13B3FD4276C5Q37800819-9DB18F09-326F-47CB-A849-E0C4D1A66541Q37842621-04DDE201-8C9D-4300-9F4F-BBEBE2EF8F07Q38152785-E52BBBD5-237E-4D2C-A8FB-542EFEDA9B80Q39610901-A3BFA675-42FD-4F00-B449-BDE0B12BDD37Q40212415-7070438B-1E7E-4FA1-84F0-2171C585E342Q40785782-2A1488EB-84C1-46A0-ADC7-A9E4C2025356Q42602855-4431FDE1-E925-4DAD-B99F-F400D4CDF70AQ43142643-41AC9488-F03A-47CD-B463-691ED6A90EE2Q54364883-B227D051-1568-41EB-BC90-8B819CDB3178
P2860
Exploitation of the nicotinic anti-inflammatory pathway for the treatment of epithelial inflammatory diseases.
description
2006 nî lūn-bûn
@nan
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Exploitation of the nicotinic ...... thelial inflammatory diseases.
@ast
Exploitation of the nicotinic ...... thelial inflammatory diseases.
@en
type
label
Exploitation of the nicotinic ...... thelial inflammatory diseases.
@ast
Exploitation of the nicotinic ...... thelial inflammatory diseases.
@en
prefLabel
Exploitation of the nicotinic ...... thelial inflammatory diseases.
@ast
Exploitation of the nicotinic ...... thelial inflammatory diseases.
@en
P2860
P356
P1476
Exploitation of the nicotinic ...... thelial inflammatory diseases.
@en
P2093
David A Scott
Michael Martin
P2860
P304
P356
10.3748/WJG.V12.I46.7451
P407
P577
2006-12-01T00:00:00Z